Corpus ID: 79501805

Neoadjuvant Chemotherapy in advanced Epithelial Ovarian cancer (EOC)

@inproceedings{Ahmad2012NeoadjuvantCI,
  title={Neoadjuvant Chemotherapy in advanced Epithelial Ovarian cancer (EOC)},
  author={Sheikh Zahoor Ahmad and Dehannathparambil Kottarathil Vijaykumar and Mariya Amin Qureishi},
  year={2012}
}
Epithelial Ovarian cancer (EOC) is one of the most common malignancies in women worldwide. Most of the patients present with advanced stage disease and need extensive cytoreductive surgery to achieve optimal debulking, which is associated with increased morbidity and mortality in most of the hands. Neoadjuvant chemotherapy (NACT) has been used by many people in this setting in an effort to downstage the disease and hence decrease the magnitude of surgery and its attendant negative outcomes… CONTINUE READING

Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

Topics from this paper.

Citations

Publications citing this paper.